The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes

10.2337/diab.3.5.419

BarnettTEpidemiology complications and costs of diabetes mellitus. InThe insulin treatment of diabetes: a practical guide ed. Tony Barnett London E‐map healthcare: 6–9 1998.

McCartyD&ZimnetPDiabetes 1994–2010: global estimates and projections. Leverkusen Bayer.: 1–46 1994.

10.1007/BF00274216

10.2337/diab.23.2.105

10.1007/BF00400195

LeeseBEconomic evaluations of Type II diabetes. In The social and cost implications of Type II diabetes ed Bengt Jönsson H Krans MJ PharmacoEconomics8(Suppl 1995;1 ): 23–27.

10.2337/diab.25.12.1129

10.1056/NEJM199309303291401

10.1097/00004872-199303000-00012

Prescott‐ClarkeP&PrimatesaPHealth Survey for England 1995London HMSO 1997.

Collins R, 1994, Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease., Br Med J, 50, 272

10.1016/S0140-6736(98)07019-6

10.1016/S0140-6736(98)07037-8

10.1016/0168-8227(95)01064-K

10.1038/370456a0

StoutRWInsulin and atherosclerosis. InDiabetes and Atherosclerosis ed Stout RW Dordrecht The Netherlands. Kluwer Academic publishers. 1992: 165–201.

10.1136/bmj.317.7160.703

UK Prospective Diabetes Study Group, 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvasvular complications in type 2 diabetes: UKPDS 39., Br Med J, 317, 713, 10.1136/bmj.317.7160.713

Curb JD, 1996, Effect of diuretic‐based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic hypertension in the Elderly Program Cooperative Resaerch Group., JAMA, 276, 1886, 10.1001/jama.1996.03540230036032

10.1016/S0140-6736(98)04311-6

Yusef S, 1997, Beta‐blockade during and after myocardial infarction; an overview of the randomised trials., Progr Cardiovascular Dis, 30, 335

10.1056/NEJM198706043162301

SOLVD Investigators, 1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions., New Eng J Med, 327, 685, 10.1056/NEJM199209033271003

10.1136/bmj.304.6823.339

10.1056/NEJM199311113292004

10.1016/S0140-6736(97)06209-0

10.1016/S0002-9149(98)00750-4

10.1136/bmj.317.7160.720